Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Patent covering MEKK-related assays licensed to Cadus

May 26, 1998

New tool identified for exploring the adenosine A3 receptor

May 25, 1998

Cell Genesys granted patent covering AAV vector technology

May 25, 1998

Therapeutic Antibodies and Searle announce research collaboration

May 25, 1998

Ribozyme progresses in target validation collaboration with Schering AG

May 25, 1998

Fuisz's EA technology improves onset of action of pain drugs

May 22, 1998

New P2Y1 antagonist will facilitate further study of the receptor and its physiological role

May 21, 1998

Lilly initiates pivotal trials with SkyePharma formulation

May 20, 1998

Phytera signs R&D and marketing agreement with NeuroSearch

May 19, 1998

Biovector licenses DNA delivery technology from NIH

May 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...